Joann Jedrusiak
About Joann Jedrusiak
Joann Jedrusiak is the Director of Corporate Communications, Public Affairs at Bristol-Myers Squibb, with extensive experience in public affairs and communications.
Current Role at Bristol-Myers Squibb
Joann Jedrusiak serves as the Director of Corporate Communications and Public Affairs at Bristol-Myers Squibb. In this role, she is responsible for overseeing communication strategies that align with the corporate mission and goals. Her duties include managing key company communications and coordinating public affairs efforts.
Previous Experience at BMS Films
Joann held the position of Director of Public Affairs at BMS Films from 2008 to 2010. During this time, she focused on managing public relations activities and supporting the company's public image through strategic communication initiatives. Her leadership helped enhance the visibility and reputation of BMS Films in the industry.
Long Tenure at Bristol-Myers Squibb
From 1979 to 2009, Joann Jedrusiak worked at Bristol-Myers Squibb as Director of Communications. Over her 30-year tenure, she played a key role in developing and implementing communication strategies that supported the company's internal and external objectives. Her responsibilities also included producing and managing the intranet and internet websites, creating annual reports, and supporting executive presentations and events.
Education at Berkeley College, NJ
Joann Jedrusiak completed her studies at Berkeley College, NJ. Her educational background provided her with the foundational skills necessary for a successful career in corporate communications and public affairs.
Contributions to Bristol-Myers Squibb
Throughout her career at Bristol-Myers Squibb, Joann Jedrusiak has made significant contributions by leading the production and maintenance of the company's intranet and internet websites. She also oversaw the creation of the annual report and corporate overview materials, which are crucial for stakeholder communications. Additionally, Joann supported various executive presentations and events, including scientific meetings and FDA Advisory Committee support, and developed tactics to aid internal initiatives.